Mounting evidence implicates acid-sensing GPCRs in the progression of various cancers, [20] with prior literature suggesting that anti-tumor effects of GPR68 inhibition involves modulation of cancer-associated fibroblasts [21, 22]. The gene discussed is GPR68; the disease is neoplasm.